Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study

BACKGROUND: In patients with severe polycystic liver disease (PLD), there is a need for new treatments. Estrogens and possibly other female sex hormones stimulate growth in PLD. In some patients, liver volume decreases after menopause. Female sex hormones could therefore be a target for therapy. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Aapkes, S. E., Bernts, L. H. P., van den Berg, A. P., van den Berg, M., Blokzijl, H., Cantineau, A. E. P., van Gastel, M. D. A., de Haas, R. J., Kappert, P., Müller, R. U., Nevens, F., Torra, R., Visser, A., Drenth, J. P. H., Gansevoort, R. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876117/
https://www.ncbi.nlm.nih.gov/pubmed/35216547
http://dx.doi.org/10.1186/s12876-022-02142-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876117/
https://www.ncbi.nlm.nih.gov/pubmed/35216547
http://dx.doi.org/10.1186/s12876-022-02142-y

Ejemplares similares